A detailed history of Auxier Asset Management transactions in Johnson & Johnson stock. As of the latest transaction made, Auxier Asset Management holds 72,621 shares of JNJ stock, worth $11.3 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares
72,621
Previous 72,779 0.22%
Holding current value
$11.3 Million
Previous $10.6 Million 10.63%
% of portfolio
1.75%
Previous 1.69%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $22,985 - $26,446
-158 Reduced 0.22%
72,621 $11.8 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $267,247 - $292,050
-1,851 Reduced 2.48%
72,779 $10.6 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $140,008 - $146,791
-902 Reduced 1.19%
74,630 $11.8 Million
Q4 2023

Feb 22, 2024

SELL
$145.6 - $158.88 $106,724 - $116,459
-733 Reduced 0.96%
75,532 $11.8 Million
Q3 2023

Nov 21, 2023

SELL
$155.75 - $174.48 $467,405 - $523,614
-3,001 Reduced 3.79%
76,265 $11.9 Million
Q2 2023

Aug 17, 2023

BUY
$154.35 - $166.11 $75,785 - $81,560
491 Added 0.62%
79,266 $13.1 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $299,834 - $357,816
1,985 Added 2.58%
78,775 $12.2 Million
Q4 2022

Feb 17, 2023

SELL
$160.2 - $179.79 $9,612 - $10,787
-60 Reduced 0.08%
76,790 $13.6 Million
Q3 2022

Nov 15, 2022

SELL
$161.33 - $179.52 $334,114 - $371,785
-2,071 Reduced 2.62%
76,850 $12.6 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $252,285 - $279,015
-1,500 Reduced 1.87%
78,921 $14 Million
Q1 2022

May 17, 2022

SELL
$158.14 - $179.59 $469,517 - $533,202
-2,969 Reduced 3.56%
80,421 $14.3 Million
Q4 2021

Mar 01, 2022

SELL
$155.93 - $173.01 $343,825 - $381,487
-2,205 Reduced 2.58%
83,390 $14.3 Million
Q3 2021

Nov 18, 2021

SELL
$161.5 - $179.47 $30,362 - $33,740
-188 Reduced 0.22%
85,595 $13.8 Million
Q2 2021

Aug 18, 2021

SELL
$159.48 - $171.07 $633,933 - $680,003
-3,975 Reduced 4.43%
85,783 $14.1 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $29,083 - $32,391
-190 Reduced 0.21%
89,758 $14.8 Million
Q4 2020

Mar 05, 2021

SELL
$137.11 - $157.38 $36,608 - $42,020
-267 Reduced 0.3%
89,948 $14.2 Million
Q3 2020

Mar 05, 2021

SELL
$140.38 - $153.83 $34,393 - $37,688
-245 Reduced 0.27%
90,215 $13.4 Million
Q2 2020

Aug 20, 2020

SELL
$128.81 - $155.51 $340,058 - $410,546
-2,640 Reduced 2.84%
90,460 $12.7 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $52,235 - $72,375
-470 Reduced 0.5%
93,100 $12.2 Million
Q4 2019

Feb 21, 2020

SELL
$127.5 - $146.44 $29,962 - $34,413
-235 Reduced 0.25%
93,570 $13.6 Million
Q3 2019

Nov 15, 2019

SELL
$126.95 - $142.14 $12,695 - $14,213
-100 Reduced 0.11%
93,805 $12.1 Million
Q2 2019

Aug 15, 2019

SELL
$131.15 - $144.24 $380,335 - $418,296
-2,900 Reduced 3.0%
93,905 $13.1 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $9,429 - $10,484
-75 Reduced 0.08%
96,805 $13.5 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $267,791 - $322,291
-2,180 Reduced 2.2%
96,880 $12.5 Million
Q3 2018

Nov 19, 2018

SELL
$121.58 - $142.88 $36,474 - $42,864
-300 Reduced 0.3%
99,060 $13.7 Million
Q2 2018

Aug 15, 2018

SELL
$119.4 - $131.76 $79,998 - $88,279
-670 Reduced 0.67%
99,360 $12.1 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $53,167 - $62,959
-425 Reduced 0.42%
100,030 $12.8 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $314,403 - $344,113
-2,396 Reduced 2.33%
100,455 $14 Million
Q3 2017

Nov 09, 2017

SELL
$129.47 - $135.38 $71,208 - $74,459
-550 Reduced 0.53%
102,851 $13.4 Million
Q2 2017

Aug 16, 2017

BUY
N/A
103,401
103,401 $13.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Auxier Asset Management Portfolio

Follow Auxier Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.